J S Lambert

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. pmc Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious
    J S Lambert
    The Institute of Human Virology, University of Maryland at Baltimore School of Medicine, 21201, USA
    Clin Diagn Lab Immunol 4:302-8. 1997
  2. ncbi request reprint HIV vaccines in infants and children
    John S Lambert
    University of Maryland Institute of Human Virology, Baltimore, USA
    Paediatr Drugs 7:267-76. 2005
  3. pmc A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil
    J S Lambert
    University of Maryland Institute of Human Virology, Baltimore, Maryland, USA
    Sex Transm Infect 79:448-52. 2003
  4. ncbi request reprint Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection
    John S Lambert
    Institute of Human Virology, University of Maryland, Baltimore, USA
    J Acquir Immune Defic Syndr 34:512-9. 2003
  5. ncbi request reprint Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)
    J S Lambert
    The Johns Hopkins University, Baltimore, Maryland, USA
    J Acquir Immune Defic Syndr Hum Retrovirol 19:451-61. 1998
  6. ncbi request reprint A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects
    J S Lambert
    Institute of Human Virology, University of Maryland, 725 West Lombard Street, Baltimore, MD21201, USA
    Vaccine 19:3033-42. 2001
  7. ncbi request reprint Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults
    J C King
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Infect Dis 181:725-8. 2000
  8. ncbi request reprint Toxoplasmic encephalitis in an HIV infected pregnant woman: successful outcome for both mother and child
    Susie Andries Nogueira
    Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro, Hospital of Lagoa, Rio de Janeiro, RJ, Brazil
    Braz J Infect Dis 6:201-5. 2002
  9. ncbi request reprint HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers
    Elizabeth J McFarland
    Department of Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver Colorado, USA
    AIDS 20:1481-9. 2006
  10. ncbi request reprint Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil
    Elizabeth S Machado
    Serviço de Doenças Infecciosas e Parasitárias, Hospital Universitario Clementino Fraga Filho, 21941 590 Rio de Janeiro, RJ, Brazil
    An Acad Bras Cienc 76:727-41. 2004

Collaborators

Detail Information

Publications17

  1. pmc Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious
    J S Lambert
    The Institute of Human Virology, University of Maryland at Baltimore School of Medicine, 21201, USA
    Clin Diagn Lab Immunol 4:302-8. 1997
    ..Fewer volunteers expressed anti-LAI rgp160 IgA antibodies in mucosal or serum specimens: 11 of 22 parotid saliva specimens, 3 of 11 SP specimens, 3 of 5 CVL samples, and 12 of 22 sera...
  2. ncbi request reprint HIV vaccines in infants and children
    John S Lambert
    University of Maryland Institute of Human Virology, Baltimore, USA
    Paediatr Drugs 7:267-76. 2005
    ..However, to date, candidate HIV vaccines capable of generating robust immunologic responses in these populations have been disappointing...
  3. pmc A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil
    J S Lambert
    University of Maryland Institute of Human Virology, Baltimore, Maryland, USA
    Sex Transm Infect 79:448-52. 2003
    ..To evaluate the safety and feasibility of zidovudine and lamivudine (AZT/3TC) given to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil...
  4. ncbi request reprint Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection
    John S Lambert
    Institute of Human Virology, University of Maryland, Baltimore, USA
    J Acquir Immune Defic Syndr 34:512-9. 2003
    ..Given that RNA assays require less blood volume and yield rapid results, our study adds to existing data suggesting that RNA assays may be used for early diagnosis of HIV-1 infection in infants...
  5. ncbi request reprint Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)
    J S Lambert
    The Johns Hopkins University, Baltimore, Maryland, USA
    J Acquir Immune Defic Syndr Hum Retrovirol 19:451-61. 1998
    ..The rgp160 and gp120 subunit vaccines were safe and immunogenic in this population...
  6. ncbi request reprint A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects
    J S Lambert
    Institute of Human Virology, University of Maryland, 725 West Lombard Street, Baltimore, MD21201, USA
    Vaccine 19:3033-42. 2001
    ..No serious adverse experiences were observed. Oral administration of this vaccine, alone or in combination with parenteral boosting, resulted in no significant humoral, cellular, or mucosal immune responses...
  7. ncbi request reprint Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults
    J C King
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Infect Dis 181:725-8. 2000
    ..The data suggest that inadvertent vaccination with LAIV in relatively asymptomatic HIV-infected adults would not be associated with frequent significant adverse events...
  8. ncbi request reprint Toxoplasmic encephalitis in an HIV infected pregnant woman: successful outcome for both mother and child
    Susie Andries Nogueira
    Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro, Hospital of Lagoa, Rio de Janeiro, RJ, Brazil
    Braz J Infect Dis 6:201-5. 2002
    ....
  9. ncbi request reprint HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers
    Elizabeth J McFarland
    Department of Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver Colorado, USA
    AIDS 20:1481-9. 2006
    ..This study evaluated the safety and immunogenicity of ALVAC HIV-1 vaccine with and without a subunit envelope boost in infants born to HIV-1-infected women...
  10. ncbi request reprint Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil
    Elizabeth S Machado
    Serviço de Doenças Infecciosas e Parasitárias, Hospital Universitario Clementino Fraga Filho, 21941 590 Rio de Janeiro, RJ, Brazil
    An Acad Bras Cienc 76:727-41. 2004
    ..To our knowledge, this is the largest pediatric cohort ever analyzed in Brazil, and the data provided is of paramount importance to a better understanding of HIV/AIDS evolution in pediatric settings...
  11. ncbi request reprint Alternative, age- and viral load-related routes of nelfinavir resistance in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy
    Elizabeth S Machado
    Serviço de Doenças Infecciosas e Parasitárias, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, RJ, Brazil
    Pediatr Infect Dis J 23:1057-9. 2004
    ..There was a significant correlation with a higher viral load and lower age and the occurrence of L90M. These findings suggest differential molecular age- and viral load-related routes for nelfinavir resistance...
  12. ncbi request reprint Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy
    Elizabeth S Machado
    Serviço de Doenças Infecciosas e Parasitárias, Hospital Universitario Clementino Fraga Filho, Rio de Janeiro, Brazil
    J Clin Virol 30:24-31. 2004
    ..However, the development of drug-resistant strains or poor adherence to therapy could impact the efficacy of this approach...
  13. ncbi request reprint Clinical manifestations of HIV infected children
    Purnima Madhivanan
    YR Gaitonde Centerfor AIDS Research and Education, Chennai, Tamil Nadu, India
    Indian J Pediatr 70:615-20. 2003
    ..Consequently, children in India increasingly getting infected, primarily from vertical transmission. A retrospective review of the profile of HIV infected children attending an HIV clinic in South India is reported...
  14. ncbi request reprint Production of the HIV-suppressive chemokines CCL3/MIP-1alpha and CCL22/MDC is associated with more effective antiretroviral therapy in HIV-infected children
    John S Lambert
    Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland
    Pediatr Infect Dis J 26:935-44. 2007
    ..Whether the release of these chemokines from lymphocytes influences treatment outcome in children receiving antiretroviral therapy is not known...
  15. pmc Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection
    John S Lambert
    Institute of Human Virology, University of Maryland, Baltimore, USA
    Clin Diagn Lab Immunol 12:622-31. 2005
    ..Detailed immunophenotyping may be useful in supporting the diagnosis of HIV infection in infants with perinatal HIV exposure...
  16. ncbi request reprint Meeting report of the 10th European AIDS Conference (EACS) 17-20 November 2005
    Nicholas Chew
    Mater University Hospital, University College Dublin, Ireland
    J HIV Ther 10:79-80. 2005
  17. ncbi request reprint Hepatitis C virus transfusion-transmitted infection in Brazilian cardiac surgery patients
    Cristiane A Villela Nogueira
    Internal Medicine and Preventive Medicine Department, Clementino Fraga Filho University Hospital, Federal Universite of Rio de Janeiro, Brazil
    Clin Lab 48:529-33. 2002
    ..27% (2/157). This study shows a high rate of HCV infection acquired post-transfusion in a cohort of surgery patients in Brazil and suggests that better screening methods such as viral RNA assessment may be effective in lowering this rate...